Skip to main content
OpenTrials

Clinical trial condition

Solid Tumor

Explore clinical trials studying Solid Tumor. Study availability and eligibility vary by location and protocol.

717 public trials 251 recruiting studies
Refine in advanced search Browse all conditions

Solid Tumor trial results

Completed

Safety Study of KPT-330 (Selinexor) in Patients With Advanced or Metastatic Solid Tumor Cancer

NCT01607905

Conditions
Adenocarcinoma, Astrocytoma, Carcinoma, +28 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • Memorial Sloan-Kettering Cancer Center New York, United States
  • Gabrail Cancer Center Canton, Ohio, United States
View Trial Details
Completed

Study of TJ210001 Administered in Subjects With Relapsed or Refractory Advanced Solid Tumors

NCT04678921

Conditions
Advanced Cancer, Metastatic Cancer, Neoplasm Metastasis, +5 more
Locations
  • University of Colorado Hospital - Anschutz Cancer Pavilion Aurora, Colorado, United States
  • Horizon Oncology Center Lafayette, Indiana, United States
  • Huntsman Cancer Institute, University of Utah Salt Lake City, Utah, United States
  • Virginia Cancer Specialists Fairfax, Virginia, United States
View Trial Details
Completed

A Study of CS1003 in Subjects With Advanced Solid Tumors or Lymphomas

NCT03809767

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations
  • Beijing Cancer Hospital Beijing, China
  • Peking Union Medical College Hospital Beijing, China
  • Peking University Third Hospital Beijing, China
  • The First Hospital of Jilin University Changchun, China
View all 17 locations
View Trial Details
Completed

Study to Evaluate the Efficacy/Safety of IPI-549 in Combination With Nivolumab in Patients With Advanced Urothelial Carcinoma (MARIO-275)

NCT03980041

Conditions
Advanced Cancer, Bladder Cancer, Carcinoma, +16 more
Locations
  • Parkview Physicians Fort Wayne, Indiana, United States
  • University of MD - Greenebaum Comprehensive Cancer Center Baltimore, Maryland, United States
  • Karmanos Cancer Center Detroit, Michigan, United States
  • Coborn Cancer Center Saint Cloud, Minnesota, United States
View all 29 locations
View Trial Details
Completed

A Study Evaluating Safety, Pharmacokinetics, and Therapeutic Activity of RO6874281 as a Single Agent (Part A) or in Combination With Trastuzumab or Cetuximab (Part B or C)

NCT02627274

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +7 more
Locations
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • UCSD - Moores Cancer Center La Jolla, California, United States
  • Banner MD Anderson Cancer Center Greeley, Colorado, United States
  • Washington University; Division of Oncology St Louis, Missouri, United States
View all 26 locations
View Trial Details
Completed

A Study of Epacadostat in Combination With Pembrolizumab and Chemotherapy in Participants With Advanced or Metastatic Solid Tumors (ECHO-207/KEYNOTE-723)

NCT03085914

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +17 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • University of California San Diego Medical Center, Moores Cancer Center La Jolla, California, United States
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • Mayo Clinic Jacksonville, Florida, United States
View all 16 locations
View Trial Details

Related conditions